首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Chinese journal of lung cancer

缩写:

ISSN:1009-3419

e-ISSN:1999-6187

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引2477
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xilan He,Jianhua Chen Xilan He
Background: Lung adenoid cystic carcinoma is a kind of rare lung cancer. Diagnosis and treatment is not enough understandable for them. We collected and analyzed 4 cases of lung adenoid cystic carcinoma for broadening the...
Liqing Lu,Chunfang Zhang,Yuanda Cheng Liqing Lu
We present a case of two-year old boy with solitary atypical adenomatous hyperplasia (AAH) in extralobar sequestration (ELS), which was misdiagnosed as diaphragmatic hernia before surgery. Review of AAH and pulmonary sequestration (PS) reve...
Yan Shi,Wang Lv,Luming Wang et al. Yan Shi et al.
Programmed death 1 (PD-1) and programmed death 1 ligand (PD-L1) pathway is a key mechanism of immune regulation, and its abnormal activation in tumor tissues suggests that PD-1/PD-L1 pathway may participate in the regulation of tumor immune...
Shiyang Yuan,Hui Xu,Junping Xie Shiyang Yuan
In recent years, targeted therapy of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKIs) is the leading treatment modality for patients with advanced non-small cell lung cancer (NSCLC) and EGFR gene mutation. However, wit...
Qianqian Song,Ke Xu Qianqian Song
MicroRNAs are a class of small noncoding RNAs (20-22 nucleotides). MicroRNAs regulate gene expression by directly binding gene's 3'-UTR regions. Many studies reveal that miRNAs play roles in tumorigenesis. MiR-26a plays different roles in d...
Xuemin Wang,Weihong Zhang,Weijiao Du et al. Xuemin Wang et al.
Background: The efficacy of second or third-line chemotherapy in advanced non-small cell lung cancer (NSCLC) patients is low. The use of targeted drugs brings survival benefit for some patients. Apatinib, as a novel small...
Hui Li,Yan Liu,Ying Liu et al. Hui Li et al.
Background: The aim of this study is to explore cytotoxic T lymphocyte associated antigen 4 (CTLA-4), programmed death 1 (PD-1) and programmed death ligand 1 (PD-L1) distribution and clinical value in liquid biopsy (such ...
Shijie Zhang,Xiangzheng Liu,Weiming Huang et al. Shijie Zhang et al.
Background: The involvement of superior vena cava is a common condition in locally advanced thoracic tumors. Patients may benefit from the high risk operation. This study proposed a programmed procedure to optimize surgic...
Ping Liu,Yuhua Wu,Lijuan Zhou et al. Ping Liu et al.
Background: Non-small cell lung cancer (NSCLC) has been transformed from the treatment according to histological type to genotype treatment model. The epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase...
Shuyang Yao,Yanfei Gu,Yi Zhang Shuyang Yao
Background: The development of new treatments beyond first-line in metastatic non-small cell lung cancer (NSCLC) contributed to the increase in overall survival. Metronomic chemotherapy involves several mechanisms of anti...